Jump Financial’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Jump Financial’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-40,667	Closed	-$1.77M	–	2381
2023 Q3	$1.77M	Buy	+40,667	New	+$1.45M	0.07%	422
2023 Q1	–	Sell	-28,422	Closed	-$1.29M	–	2156
2022 Q4	$1.29M	Buy	+28,422	New	+$1.84M	0.07%	389
2022 Q3	–	Sell	-3,768	Closed	-$253K	–	2088
2022 Q2	$253K	Sell	3,768 -40,453	-91%	-$2.57M	0.01%	1152
2022 Q1	$3.64M	Buy	+44,221	New	+$4.52M	0.15%	145

Other funds holding MRTX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return

Braslyn New Providence, Bahamas $7.81M AUM 338.68% 1-Year Est. Return

Jump Financial's MRTX Position: Q4 2023 in Review

Jump Financial sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2023, closing a stake of 40,667 shares — an estimated $1.77M sold.

Jump Financial first reported a position in MRTX in Q1 2022 and held it in 4 quarters. The position peaked at $3.64M in Q1 2022. 217 funds tracked by Wall St. Rank hold MRTX as of Q4 2023.

Jump Financial reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Jump Financial sold 40,667 Mirati Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $1.77M.
Jump Financial first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Jump Financial's Mirati Therapeutics, Inc. Common Stock position peaked at $3.64M in Q1 2022.
217 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Jump Financial's 13F filing for Q4 2023, filed 7 Feb 2024.